Contact

Contact GlycoNex

Reach the right team directly. Select the inquiry type below and indicate the matching subject line in your email — your message goes straight to the people who handle it.

Email
mail@glyconex.com.tw
Phone
+886-2-2697-4168
Headquarters
New Taipei City, Taiwan
Listing
TWO:4168 (Taipei Exchange)
01 — Inquiry Routing

Choose the Right Channel

01

Partnering & Licensing

For global licensing, co-development, and out-licensing discussions across our Phase 1+ pipeline.

mail@glyconex.com.tw
Subject: Partnering Inquiry
02

CDMO & Manufacturing

For antibody contract development, GMP manufacturing, and glycan analytical services.

mail@glyconex.com.tw
Subject: CDMO Inquiry
03

Investor Relations

For shareholders, analysts, and institutional investors.

mail@glyconex.com.tw
Subject: Investor Relations
04

Media & Press

For press, interviews, and media inquiries.

mail@glyconex.com.tw
Subject: Media Inquiry
02 — General & Headquarters

General Inquiries

For all other inquiries, email mail@glyconex.com.tw — no subject line required. A subject line is only needed for the four channels above. GlycoNex responds in English and Traditional Chinese.

GlycoNex, Inc. (TWO:4168) 8F, No. 97, Sec. 1, Xintai 5th Rd., Xizhi District
New Taipei City 221, Taiwan
Tel: +886-2-2697-4168
Email: mail@glyconex.com.tw
Continue exploring
Partnering Licensing and co-development opportunities. View partnering → CDMO Services Contract development and GMP manufacturing. View CDMO → Investors Financials, governance, and disclosures. View investors →